Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2

被引:23
|
作者
Zheng, Fang [1 ]
Zheng, Guangrong [1 ]
Deaciuc, A. Gabriela [1 ]
Zhan, Chang-Guo [1 ]
Dwoskin, Linda P. [1 ]
Crooks, Peter A. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
lobeline analog; QSAR; partial least squares; artificial neural network; VMAT2;
D O I
10.1016/j.bmc.2007.02.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Back-propagation artificial neural networks (ANNs) were trained on a dataset of 104 VMAT2 ligands with experimentally measured log(l/K-i) values. A set of related descriptors, including topological, geometrical, GETAWAY, aromaticity, and WHIM descriptors, was selected to build nonlinear quantitative structure-activity relationships. A partial least squares (PLS) regression model was also developed for comparison. The nonlinearity of the relationship between molecular descriptors and VMAT2 ligand activity was demonstrated. The obtained neural network model outperformed the PLS model in both the fitting and predictive ability. ANN analysis indicated that the computed activities were in excellent agreement with the experimentally observed values (r(2) = 0.91, rmsd = 0.225; predictive q(2) = 0.82, loormsd = 0.316). The generated models were further tested by use of an external prediction set of 15 molecules. The nonlinear ANN model has r(2) = 0.93 and root-mean-square errors of 0.282 compared with the experimentally measured activity of the test set. The stability test of the model with regard to data division was found to be positive, indicating that the generated model is predictive. The modeling study also reflected the important role of atomic distribution in the molecules, size, and steric structure of the molecules when they interact with the target, VMAT2. The developed models are expected to be useful in the rational design of new chemical entities as ligands of VMAT2 and for directing synthesis of new molecules in the future. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2975 / 2992
页数:18
相关论文
共 50 条
  • [31] 9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitors
    Wang, Wenyan
    Lin, Shilan
    Du, Guangying
    Bai, Xinfa
    Lu, Jing
    Ye, Liang
    Wang, Hongbo
    Zhang, Rui
    Tian, Jingwei
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (13) : 991 - 1003
  • [32] Synthesis and evaluation of 2-amino-dihydroxytetrabenazine derivatives as probes for the vesicular monoamine transporter-2
    Zhu, Lin
    Liu, Jingying
    Kung, Hank F.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [33] Dopamine D2 receptor agonists increase vesicular monoamine transporter-2 function
    Truong, JG
    Rau, KS
    Hanson, GR
    Fleckenstein, AE
    FASEB JOURNAL, 2003, 17 (05): : A1025 - A1025
  • [34] Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2
    Noskova, Vera
    Bottalico, Barbara
    Olsson, Hanna
    Ehinger, Anna
    Pilka, Radovan
    Casslen, Bertil
    Hansson, Stefan R.
    MOLECULAR HUMAN REPRODUCTION, 2006, 12 (08) : 483 - 489
  • [35] Age-Dependent Differences in Dopamine Transporter and Vesicular Monoamine Transporter-2 Function and Their Implications for Methamphetamine Neurotoxicity
    Volz, Trent J.
    Farnsworth, Sarah J.
    Rowley, Shane D.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    SYNAPSE, 2009, 63 (02) : 147 - 151
  • [36] Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2
    Nickell, Justin R.
    Culver, John P.
    Janganati, Venumadhav
    Zheng, Guangrong
    Dwoskin, Linda P.
    Crooks, Peter A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (18) : 4441 - 4445
  • [37] The Effect of APOE ε4 on Striatal Vesicular Monoamine Transporter-2 Density in Parkinson's Disease
    Li, W.
    Li, R.
    Lu, J.
    MOVEMENT DISORDERS, 2023, 38 : S695 - S695
  • [38] The effect of APOE ε4 on striatal vesicular monoamine transporter-2 density in Parkinson's disease
    Li, W.
    Li, R.
    Lu, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 308 - 308
  • [39] Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein
    Truong, JG
    Newman, AH
    Hanson, GR
    Fleckenstein, AE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 504 (1-2) : 27 - 32
  • [40] Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2
    Zhu, Lin
    Liu, Jingying
    Kung, Hank F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (17) : 5026 - 5028